Local view for "http://purl.org/linkedpolitics/eu/plenary/2012-09-11-Speech-2-378-000"

Predicate	Value (sorted: default)
rdf:type	lpv_eu:Speech2
dcterms:Date	"2012-09-11"^^xsd:date2
dcterms:Is Part Of	lp_eu:Explanations of vote2
dcterms:Language	"pt"^^xsd:language2
lpv:document identification number	"en.20120911.32.2-378-000"2
lpv:hasSubsequent	lp_eu:2012-09-11-Speech-2-378-5002
lpv:speaker	lp:João Ferreira2
lpv:spokenAs	member; Delegation to the EU-Former Yugoslav Republic of Macedonia Joint Parliamentary Committee (2009-09-16--2013-02-03)3 unknown; Partido Comunista Português (2009-07-14--2014-06-30)3 substitute; Delegation for relations with the countries of the Andean Community (2009-09-16--2014-06-30)3 vice-chair; EUL/NGL (2012-02-07--2014-06-30)3 member; PECH (2012-01-19--2014-06-30)3 member; Delegation to the ACP-EU Joint Parliamentary Assembly (2009-09-16--2014-06-30)3 substitute; ENVI (2012-01-19--2014-06-30)3 substitute; BUDG (2012-01-19--2014-06-30)3
lpv:translated text	"Like the changes to Directive 2001/83/EC, the amendment of this regulation constitutes another step in modifying the pharmacovigilance system; that is, the system for evaluating, detecting and preventing adverse reactions to medicines. In general, we support the measures that have been made in this regard, the need for which has been made clear by the numbers of deaths associated with adverse reactions to medicines. The objectives of this revision should be guided by strict prevention and health protection criteria, so any other considerations relating to strengthening the internal market and its workings are dispensable. In general, the rapporteur makes a serious effort to correct the shortcomings identified in the EU pharmacovigilance system, thereby making the system more transparent and efficient in cases where safety problems are identified. It aims to guarantee that the volume of work of the Pharmacovigilance Risk Assessment Committee remains manageable, and to ensure that patients and health sector professionals are fully involved in pharmacovigilance."@en1
lpv:unclassifiedMetadata	"inter alia"1

Named graphs describing this resource:

The resource appears as object in 2 triples

Context graph